Member Info for Saxondale

Very good presentation .
A real showcase for the team and Bexmarilimab - which seems to have taken over all the limelight recently .
Next update should be the dosing and frequency - and the all important soluble clever 1 data .

Interesting they noted that in the way they are developing this therapy - A similar strategy has been successfully utilised by major checkpoints, such as Keytruda, Opdivo and Yervoy

This shows how there is a clear path to market with Bexmalilimab , as these immunotherapy drugs have already made it .

https://www.keytruda.com/
https://www.opdivo.com/
https://www.yervoy.com/

All that cash puts them in great strategic position for acquisitions , mergers , and expansion .
They aren't sitting on their hands .
LFT , US entry . It just goes on .

Looks like Matins trial info just gets better again .
Up to 36% now from 33% in disease control in their melanoma cohort .
And in cancer terms , mindful to note that a 10% success rate is seen as pretty good result .

That is a pretty damn good RNS .
Lots to digest
Big numbers , and big ambitions
Well done

Calibre look to be a pretty big set up .
They have acquired a lot of companies over the last few years
Also have a UK HQ in Sheffield

Non exclusive agreement - plenty more to come .

Clinical trial site showing 2 more sites added , Michigan USA , and also Buenos Aires Argentina .
That makes at least 8 sites added in the last 2 weeks or so .
No slowing down by the looks of it .
Can't wait for the next update from Bush Lightyear

Only another 50p and I'll be in the blue again !
Nice to see some action in an upwards direction at last .
I remember the good old 20% a day rises . The 4pm RNS's . The booms .
About time this share got back to where it belongs .
Make that 40p :-)

Going on their track record - it wouldn't surprise me if that wasn't the official Innova.
Its been running for a while now - obviously got bigger fish to fry than taking a down a spoof twitter handle .
Amazing that the companies website just shows a frazzled plonker - and that the address on the test packets is some 1 bedroom flat on a housing estate .
Maybe thats how big business works these days ?

For even longer term shelf life , it is possible to freeze dry Interferon Beta too .
Something they may want to look into further down the road regarding stockpiling.

Special note should go for the new 'ginger tom ' beard .
Buzz Lightyear was so last year . Possibly going for the David Bellamy now , or the Bruce Willis wilderness look lol

Having to read from script as - can not afford to slip out any extra info - even if just a side comment as that would infer market sensitive info - hence why a bit stilted .
Lots at stake here - can't do a Castro

Govts interested in stockpiling - long term substantial opportunity .
Dialogues with many - who are following progress .
Good shelf life - 3 yrs
Happy that it works with all variants
Robust IP estate
Long covid effects still being assessed
Currently working on price mechanisms
Supportive interaction with regulators
Regular discussions with Govts around the world - with accelerating Govt plans to bring forward treatments in general .

Personally I was hoping the Chinese anal swab was going to make a comeback as the best test , simply for the amusement factor of watching people fiddling around with their trousers whilst waiting to get into a sporting event or on an airplane .

Yes just watched that bit Dan , and yes he seems to know more than he is willing to tell .
Faron have filed patents back in January regarding the new discoveries about S Clever 1.
He is our famous ' One ring to rule them all ' man .
Both he and Maija are great ambassadors for Farons work .

LSE London does show a 180.80 purchase , but only £400 odd - a ECEU trade whatever that is , probably a late one from a day or so ago catching up .
When news breaks , its gonna whack a lot higher than £1.80 believe me

Lets hope its a real one , not a Han**** tear - created by sitting on his thumb I believe .

https://www.youtube.com/watch?v=i4Ils4kpJuM&t=905s

Maija Hollmén is first on - giving a run down of how important innate immune cells are to the process of treating tumours.
Very good .

Dr Juho Jalkanen starts at about 14 mins in - giving an overview of Bexmarlimab .
Good presentation again - showing as slide at about 24 mins headed ' A dramatic turn around fro last line patients '

Wait until they get Dr Emma Royd on for an interview .

I think Faron had stated that it had received the funds from the DoD .
Perhaps the delay is just getting allocation of patients in these hospitals .
I expect so many trials have been initiated in the last year , they are fighting over patients , particularly when it is Harvard University etc - the most highly sought after medical school.

My take is that with no RNS from SNG to quash the rumour , chances are more than 50% that the Kansas Doc was just saying the truth , but they had to correct it , as it had not been formally announced and he had jumped the gun .
He knew what he was saying .
Formally it is still on P2 until it is formally announced as being on P3 .

If the SP gets wildly out of shape today - perhaps they will have to issue an intra day RNS .